| Dr Robert D Smink Jr, MD | |
|
100 E Lancaster Ave, Wynnewood, PA 19096-3450 | |
| (610) 642-1908 | |
| (610) 642-6808 |
| Full Name | Dr Robert D Smink Jr |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 100 E Lancaster Ave, Wynnewood, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003819079 | NPI | - | NPPES |
| 000703136-0003 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD012400E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert D Smink Jr, MD 100 E Lancaster Ave, Wynnewood, PA 19096-3450 Ph: (610) 642-1908 | Dr Robert D Smink Jr, MD 100 E Lancaster Ave, Wynnewood, PA 19096-3450 Ph: (610) 642-1908 |
News Archive
A new National Academy of Sciences report identifies tools that would help miners devise their own means of escape when trapped underground.
When temperatures reach 32-C or higher over a period of four to seven days, the risk of early-term delivery is 27% higher than on typical summer days, according to a study led by Nathalie Auger of the University of Montreal's Department of Social and Preventive Medicine. The study involved data from 300,000 births that took place in Montreal between 1981 to 2010 with summer temperatures recorded by Environment Canada during this period. Auger is also affiliated with the university's CHUM Superhospital Research Centre.
The Human Factors and Ergonomics Society has just released the preliminary program for the 2013 International Symposium on Human Factors & Ergonomics in Health Care: Advancing the Cause, to be held March 10-13, 2013, in Baltimore MD USA.
Few people were surprised last week when the Trump administration issued a rule to make it easier for some religious employers to opt out of offering no-cost prescription birth control to their female employees under the Affordable Care Act.
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
› Verified 2 days ago
Arvind Sabesan, Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave Ste 275, Wynnewood, PA 19096 Phone: 610-642-1908 | |
Dr. Thais Reif De Paula, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 100 E Lancaster Ave, Mob South 422, Wynnewood, PA 19096 Phone: 484-476-1619 Fax: 484-476-3354 | |
Pranjal Thosani, DO Surgery Medicare: Medicare Enrolled Practice Location: 100 E Lancaster Ave, Wynnewood, PA 19096 Phone: 484-476-2000 | |
Dr. W Randall Russell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, Suite 151 Lankenau Mob East, Wynnewood, PA 19096 Phone: 484-476-6492 Fax: 484-476-8147 | |
Dr. Barry D Mann, MD Surgery Medicare: Medicare Enrolled Practice Location: 100 E Lancaster Ave, Suite 275 Med Sci Bldg, Wynnewood, PA 19096 Phone: 610-642-1908 Fax: 610-642-6808 | |
Dr. Shari Nolana Reid-gruner, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave Ste 275, Wynnewood, PA 19096 Phone: 845-720-1714 Fax: 484-476-1395 |